Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | MQ710 |
Trade Name | |
Synonyms | MQ-710|MQ 710 |
Drug Descriptions |
MQ710 is a cancer vaccine comprising a modified vaccinia virus Ankara engineered with deletion of the viral E5R gene and to express FLT3L and OX40L, which potentially increases interferon signaling and cytokine release, reduces immunosuppression, and enhances antitumor immune response (NCI Drug Dictionary). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C199613 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
MQ710 | MQ710 | 0 | 1 |
MQ710 + Pembrolizumab | MQ710 Pembrolizumab | 0 | 1 |